דוחות כספיים מלאים לרבעון השלישי 2026
false
טבע תעשיות פרמצבטיות בע"מ
2
380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no:
520013954
10205
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
03/11/2026
www.isa.gov.il
www.tase.co.il
Reference:
2026-02-098720
Time of broadcast:
23:18
23:18
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
דוחות כספיים מלאים לרבעון השלישי 2026
2026_Q3_10Q__final_bannerless_isa.pdf
For an accessible version of this Quarterly Report on Form 10-Q, please visit www.tevapharm.com
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NYSE
Date of revision of form structure:
06/08/2024
Address:
Dvora Hanevi'a
124
,
Tel Aviv
6944020
,
Tel:
03-9148262
,
Fax:
03-9267519
E-mail address:
Yael.Ashman@teva.co.il
Previous names of reporting entity:
Name of the Signatory:
Bergwerk Dov
Position of Signatory in the reporting corporation:
General Counsel & Corporate Secretary
Name of Employer Company:
Address:
Dvora Ha'Nevia
124
,
Tel Aviv
6944020
Telephone:
050-8560290
Facsimile:
E-mail:
matan.kimchi@teva.co.il
1